lithium has been researched along with kynurenine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Slaughter, MM; Stockton, RA | 1 |
| Endres, M; Fidzinski, P; Gertz, K; Göttert, R; Holtkamp, M; Kraus, L; Kronenberg, G; Schneider, UC | 1 |
2 other study(ies) available for lithium and kynurenine
| Article | Year |
|---|---|
Depolarizing actions of GABA and glycine on amphibian retinal horizontal cells.
Topics: Animals; Baclofen; Bicuculline; Cobalt; GABA Antagonists; gamma-Aminobutyric Acid; Glycine; In Vitro Techniques; Kynurenine; Lithium; Neuromuscular Depolarizing Agents; Nicotinic Acids; Picrotoxin; Receptors, GABA-A; Retina; Urodela | 1991 |
Lithium inhibits tryptophan catabolism via the inflammation-induced kynurenine pathway in human microglia.
Topics: Glycogen Synthase Kinase 3; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Induced Pluripotent Stem Cells; Inflammation; Kynurenine; Lithium; Microglia; Tryptophan | 2022 |